Modus Therapeutics Holding AB announced interim report for the second quarter and first half of 2021. For the quarter, the company reported The loss after tax amounted to SEK 2,533,000 against SEK 1,698,000 a year ago. For the first half, the company reported the loss after tax amounted to SEK 3,961,000 against SEK 4,303,000 a year ago.